Avadel Pharmaceuticals PLC (AVDL) — Cash Flow-to-Debt Ratio
Avadel Pharmaceuticals PLC (AVDL) has a Cash Flow-to-Debt Ratio of 0.23x as of September 2025, meaning its operating cash flow of $23.26 Million could theoretically repay 0% of its total liabilities ($101.22 Million) in one year. Check Avadel Pharmaceuticals PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Avadel Pharmaceuticals PLC Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Avadel Pharmaceuticals PLC across 29 annual periods. Also explore AVDL total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Avadel Pharmaceuticals PLC (1996–2024)
Year-by-year debt coverage analysis for Avadel Pharmaceuticals PLC. For market capitalisation and broader financial context, see Avadel Pharmaceuticals PLC stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.52x | $-46.91 Million | $90.39 Million | ▲ +68.9% |
| 2023 | -1.67x | $-128.51 Million | $76.96 Million | ▼ -265.6% |
| 2022 | -0.46x | $-70.30 Million | $153.93 Million | ▲ +0.1% |
| 2021 | -0.46x | $-77.31 Million | $169.02 Million | ▼ -40.2% |
| 2020 | -0.33x | $-48.73 Million | $149.37 Million | ▼ -53.8% |
| 2019 | -0.21x | $-38.33 Million | $180.63 Million | ▲ +51.9% |
| 2018 | -0.44x | $-82.72 Million | $187.52 Million | ▼ -543.5% |
| 2017 | 0.10x | $16.66 Million | $167.54 Million | ▲ +7.0% |
| 2016 | 0.09x | $18.90 Million | $203.41 Million | ▼ -83.8% |
| 2015 | 0.57x | $84.29 Million | $147.11 Million | ▲ +905.7% |
| 2014 | -0.07x | $-10.62 Million | $149.31 Million | ▲ +56.7% |
| 2013 | -0.16x | $-20.68 Million | $125.76 Million | ▲ +38.3% |
| 2012 | -0.27x | $-23.14 Million | $86.81 Million | ▼ -2.3% |
| 2011 | -0.26x | $-10.32 Million | $39.61 Million | ▼ -83.0% |
| 2010 | -0.14x | $-5.46 Million | $38.31 Million | ▼ -185.9% |
| 2009 | 0.17x | $8.20 Million | $49.43 Million | ▲ +195.6% |
| 2008 | -0.17x | $-7.51 Million | $43.31 Million | ▲ +57.9% |
| 2007 | -0.41x | $-19.24 Million | $46.77 Million | ▲ +42.3% |
| 2006 | -0.71x | $-29.83 Million | $41.87 Million | ▼ -38.5% |
| 2005 | -0.51x | $-19.39 Million | $37.70 Million | ▼ -257.6% |
| 2004 | -0.14x | $-4.15 Million | $28.85 Million | ▼ -141.4% |
| 2003 | 0.35x | $12.23 Million | $35.19 Million | ▼ -57.3% |
| 2002 | 0.81x | $8.77 Million | $10.79 Million | ▲ +410.5% |
| 2001 | -0.26x | $-2.78 Million | $10.63 Million | ▲ +55.9% |
| 2000 | -0.59x | $-5.62 Million | $9.48 Million | ▲ +18.1% |
| 1999 | -0.72x | $-4.24 Million | $5.85 Million | ▲ +33.4% |
| 1998 | -1.09x | $-8.19 Million | $7.53 Million | ▲ +12.1% |
| 1997 | -1.24x | $-8.90 Million | $7.20 Million | ▼ -100.1% |
| 1996 | -0.62x | $-4.20 Million | $6.80 Million | — |